54
Participants
Start Date
July 20, 2023
Primary Completion Date
October 22, 2025
Study Completion Date
August 19, 2026
Atrasentan
Period A (12 Weeks) - Film-coated tablet, Washout Period: 12 weeks, Period B (24 Weeks) - Placebo
Atrasentan
Period B (12 Weeks) - Placebo, Washout Period: 12 weeks, Period A (24 Weeks) - Film-coated tablet
Placebo
Placebo
Prince of Wales Hospital, Sydney
The St. George Hospital, Kogarah
Sunshine Hospital, St Albans
Monash Health- Monash Medical Centre, Melbourne
Hallym University Sacred Heart Hospital, Anyang-si
University of Pennsylvania, Philadelphia
Hospital Ribera Polusa, Lugo
University of North Carolina at Chapel Hill - Nephrology and Hypertension, Chapel Hill
Hospital Universitario De Getafe (HUG), Madrid
Hospital 12 de Octubre, Madrid
Fides Clinical Research, Atlanta
Hospital Raja Permaisuri Bainun (HRPB), Ipoh
Soon Chun Hyang Central Medical Center (SCHMC) - Soon Chun Hyang University Hospital, Cheonan
University of Alabama at Birmingham (UAB) - The Kirklin Clinic (TKC) - Nephrology Clinic, Birmingham
Hospital Virgen Macarena, Seville
Hospital Clinico Universitario, Valencia
Dong-A University Medical Center (Dong-A University Hospital), Busan
Universiti Kebangsaan Malaysia (UKM) - Medical Centre (Pusat Perubatan) (Hospital Canselor Tuanku Muhriz (HCTM)), Cheras
University Malaya Medical Centre, Kuala Lumpur
NANI Research, Oak Brook
Hopsital Sultanah Aminah Johor Bharu (HSAJB) - Bangunan Bakawali Heodialysis Centre, Johor Bahru
Tufts Medical Center, Boston
NUPEC Cardio, Belo Horizonte
Santa Casa de Misericordia de Porto Alegre, Porto Alegre
Universidade Federal de Sao Paulo, São Paulo
Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo
Chung-Ang University College, Seoul
Hospital Torrecardenas, Almería
Hospital del Mar, Barcelona
Hospital del Vall d´Hebron, Barcelona
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY